Screener
Quest Diagnostics DGX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Quest Diagnostics’s reported figures.
Based on trailing twelve months.
The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001022079-26-000070
FAQ
- What is Quest Diagnostics's return on equity?
- Quest Diagnostics (DGX) reported return on equity of 14.4% in Q2 2026.
- How has Quest Diagnostics's return on equity changed year-over-year?
- Quest Diagnostics's return on equity increased by 5.0% year-over-year, from 13.7% to 14.4%.
- What is the long-term trend for Quest Diagnostics's return on equity?
- Over 5 years (2020 to 2025), Quest Diagnostics's return on equity has grown at a -9.2% compound annual growth rate (CAGR), from 23.1% to 14.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Quest Diagnostics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude